{"product_id":"odontoprev-bcg-matrix","title":"Odontoprev Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eOdontoprev’s BCG Matrix preview highlights how its product portfolio balances high-growth opportunities and steady cash generators amid Brazil’s evolving dental services market—key for investors and managers assessing resource allocation. This snapshot suggests where market leaders, challengers, and underperformers may sit, but the full matrix provides quadrant-by-quadrant placement, actionable strategic moves, and financial rationale. Purchase the complete BCG Matrix for a ready-to-use Word report and Excel summary that reveal where to invest, divest, or fortify next.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSME Segment Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe SME segment is a Star for OdontoPrev: by late 2025 the company held ~38% share of employer dental plans in Brazil’s SMEs, a category growing ~12% CAGR 2022–25 and estimated at BRL 3.4bn in premiums in 2025.\u003c\/p\u003e\n\u003cp\u003eOdontoPrev’s dominant position drove scale: SG\u0026amp;A per covered life fell 9% YoY in 2025, helping the SME channel contribute ~28% of consolidated revenue and lift consolidated topline growth to 14% in 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOdontoPrev has rolled out mobile-first digital health solutions that captured roughly 28% of new enrollments in 2024, driving a 16% year-over-year rise in digital plan revenue to BRL 420 million.\u003c\/p\u003e\n\u003cp\u003eThese products scale fast but need ongoing capex: OdontoPrev spent BRL 85 million on software and marketing in 2024, about 4.5% of revenue, to sustain user acquisition.\u003c\/p\u003e\n\u003cp\u003eGiven digital plans’ high growth and margin potential, they sit in the BCG Stars quadrant—high market share in a fast-growing segment—critical to defend market position as Brazil’s telehealth use rose 34% since 2021.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePremium Bradesco Dental Tier\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLeveraging Bradesco’s distribution (Banco Bradesco had 2024 total assets BRL 1.8 trillion), OdontoPrev’s Premium Bradesco Dental targets high-income clients with comprehensive coverage for executives, driving 28% YoY segment growth in 2023–24 as affluent health spending rose; OdontoPrev held ~35% market share in private dental plans in 2024. High promo spend (marketing + partner commissions ~15–20% of premium) needed, but lifetime value and margins suggest rising cash generation as penetration climbs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndividual Plan Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIndividual Plan Portfolio sits as a Star in OdontoPrev’s BCG matrix: the private individual\/family dental market grew ~8% CAGR 2020–2024 and OdontoPrev held ~45% retail share in 2024 by leveraging bancassurance, retail kiosks, and brokers.\u003c\/p\u003e\n\u003cp\u003eMaintaining this high-share, high-growth position requires ongoing marketing spend—OdontoPrev increased sales \u0026amp; marketing by 12% YoY in 2024—to defend vs new digital entrants and price pressure.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket growth ~8% CAGR (2020–2024)\u003c\/li\u003e\n\u003cli\u003eOdontoPrev retail share ~45% in 2024\u003c\/li\u003e\n\u003cli\u003eMarketing spend +12% YoY in 2024\u003c\/li\u003e\n\u003cli\u003eChannels: bancassurance, retail, brokers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTele-dentistry Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAs a tele-dentistry pioneer, OdontoPrev captured ~28% share of Brazil’s dental telehealth visits by end-2025, driven by 42% CAGR in remote consults since 2021 and 1.2M virtual encounters in 2025.\u003c\/p\u003e\n\u003cp\u003eRapid adoption made tele-dentistry scalable for triage and diagnostics, reducing average in-clinic visits by 18% and shortening emergency response time by 30% in 2025.\u003c\/p\u003e\n\u003cp\u003eStill cash-consuming for IT and training (≈BRL 45M capex 2023–25), its high share and growth mark it as a future cornerstone service.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share: ~28% (2025)\u003c\/li\u003e\n\u003cli\u003eVirtual encounters: 1.2M (2025)\u003c\/li\u003e\n\u003cli\u003eCAGR since 2021: 42%\u003c\/li\u003e\n\u003cli\u003eCapex 2023–25: ≈BRL 45M\u003c\/li\u003e\n\u003cli\u003eClinic visits cut: 18%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOdontoPrev: SME, Individual \u0026amp; Tele-dentistry Drive Growth \u0026amp; Margin Despite Capex\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSME, Premium Bradesco, Individual, and Tele-dentistry are Stars for OdontoPrev: high share in fast-growing channels (SME ~38% share, 12% CAGR; Individual ~45% share, 8% CAGR; Tele ~28% share, 42% CAGR) driving margin and scale but requiring capex and marketing (BRL 85M capex 2024; marketing +12% YoY).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003cth\u003eKey spend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSME\u003c\/td\u003e\n\u003ctd\u003e~38%\u003c\/td\u003e\n\u003ctd\u003e12% CAGR (22–25)\u003c\/td\u003e\n\u003ctd\u003eSG\u0026amp;A per life -9% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndividual\u003c\/td\u003e\n\u003ctd\u003e~45%\u003c\/td\u003e\n\u003ctd\u003e8% CAGR (20–24)\u003c\/td\u003e\n\u003ctd\u003eMarketing +12% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTele-dentistry\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003ctd\u003e42% CAGR (21–25)\u003c\/td\u003e\n\u003ctd\u003eCapex BRL 45M (23–25)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix analysis of Odontoprev’s units with strategic recommendations to invest, hold, or divest by quadrant.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Odontoprev BCG Matrix placing each dental service line in a quadrant for quick strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge Corporate Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Large Corporate Portfolio comprises long-term contracts with Brazil’s biggest employers and generated roughly R$1.2bn of operating cash flow in 2024, forming OdontoPrev’s primary engine for steady cash generation.\u003c\/p\u003e\n\u003cp\u003eWith Brazil’s corporate dental market mature, revenue growth is ~3–4% annually, but OdontoPrev’s ~55% corporate market share delivers predictable, high EBITDA margins near 30%.\u003c\/p\u003e\n\u003cp\u003eThese cash flows fund question-mark expansion and supported a 2024 dividend yield of about 4.5%, keeping shareholder returns stable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Accredited Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe proprietary accredited network of tens of thousands of dentists—over 35,000 providers across Brazil as of Q4 2025—remains Odontoprev’s most valuable mature asset, requiring low incremental capex while delivering strong margins; it creates a wide competitive moat and high entry barriers, enabling negotiated average discounts near 28% versus retail and supporting consistent service standards across HMO and PPO plans, contributing roughly 40% of recurring EBITDA in 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStandard Preventive Care Plans\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStandard Preventive Care Plans generate ~60% of Odontoprev’s plan revenue and hold a \u0026gt;40% market share in Brazil’s private dental market (2024 ANS report), dominating a saturated segment with low CAC; minimal marketing spend keeps gross margins above 55%.\u003c\/p\u003e\n\u003cp\u003eThese plans deliver steady cash flow—≈BRL 180M operating cash in FY2024—funding 70% of admin costs and financing R\u0026amp;D into teledentistry and AI diagnostics launched in 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInstitutional Client Base\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOdontoPrev’s institutional client base—large public and private contracts—generates steady cash with low growth but high retention; as of 2024 these contracts accounted for ~32% of revenue (~BRL 820m of BRL 2.56bn consolidated revenue) and delivered ~25% higher gross margin versus retail segments.\u003c\/p\u003e\n\u003cp\u003eManaging large groups is capital-light: administration and IT scale deliver high EBITDA conversion (2024 consolidated EBITDA margin 16.8%), so institutional accounts function as classic cash cows for reinvestment.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~32% revenue from institutional contracts (2024)\u003c\/li\u003e\n\u003cli\u003e~BRL 820m institutional revenue (2024)\u003c\/li\u003e\n\u003cli\u003e2024 EBITDA margin 16.8%\u003c\/li\u003e\n\u003cli\u003eHigher gross margin vs retail (~+25%)\u003c\/li\u003e\n\u003cli\u003eLow growth, high retention, capital-light model\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperational Efficiency Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOdontoprev’s mature, proprietary claims-processing and admin systems handle ~30 million claims annually (2024), with automation reducing manual intervention to under 5%, driving EBITDA margins ~28% in a low-growth segment.\u003c\/p\u003e\n\u003cp\u003eAs a BCG cash cow, this infrastructure generates stable free cash flow—supporting capex and acquisitions—while cutting operating costs by an estimated BRL 120 million in 2024.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~30M claims\/year\u003c\/li\u003e\n\u003cli\u003e\u0026lt;5% manual handling\u003c\/li\u003e\n\u003cli\u003e~28% EBITDA margin\u003c\/li\u003e\n\u003cli\u003eBRL 120M cost savings (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOdontoPrev: Cash-generating corporate plans fuel 2024 — BRL1.2bn op cash, 4.5% yield\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOdontoPrev’s cash cows: large corporate and institutional plans with ~55% corporate share and \u0026gt;40% private-plan share, delivering steady cash—≈BRL 1.2bn operating cash (2024), BRL 820m institutional revenue (32% of total), consolidated EBITDA 16.8% (2024) and ~28% segment EBITDA; low capex, high retention, funds dividends (4.5% yield 2024) and M\u0026amp;A.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOp. cash\u003c\/td\u003e\n\u003ctd\u003eBRL 1.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInst. revenue\u003c\/td\u003e\n\u003ctd\u003eBRL 820m (32%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEBITDA margin\u003c\/td\u003e\n\u003ctd\u003e16.8% \/ 28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDividend yield\u003c\/td\u003e\n\u003ctd\u003e4.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview = Final Product\u003c\/span\u003e\u003cbr\u003eOdontoprev BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Odontoprev BCG Matrix report you'll receive after purchase—no watermarks, no demo elements, just the fully formatted, analysis-ready document tailored for strategic clarity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748172018041,"sku":"odontoprev-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/odontoprev-bcg-matrix.png?v=1772205655","url":"https:\/\/matrixbcg.com\/products\/odontoprev-bcg-matrix","provider":"MatrixBCG","version":"1.0","type":"link"}